- Home
- TDOC vs IMTX Comparison
TDOC vs IMTX Comparison
Compare TDOC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TDOC | IMTX |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | TDOC | IMTX |
|---|---|---|
| Price | $7.70 | $10.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | $9.54 | ★ $19.25 |
| AVG Volume (30 Days) | ★ 5.5M | 646.5K |
| Earning Date | 10-29-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,528,199,000.00 | $99,445,031.00 |
| Revenue This Year | $0.13 | N/A |
| Revenue Next Year | $1.09 | $24.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.35 | $3.30 |
| 52 Week High | $15.21 | $12.41 |
Technical Indicators
Market Signals| Indicator | TDOC | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.46 | 48.79 |
| Support Level | $7.41 | $9.75 |
| Resistance Level | $7.84 | $12.41 |
| Average True Range (ATR) | 0.26 | 0.76 |
| MACD | 0.08 | -0.10 |
| Stochastic Oscillator | 84.69 | 10.15 |
Price Performance
Historical ComparisonAbout TDOC Teladoc Health Inc.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.